255 related articles for article (PubMed ID: 6765955)
1. Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes.
Staal GE; Stoop JW; Zegers BJ; Siegenbeek van Heukelom LH; van der Vlist MJ; Wadman SK; Martin DW
J Clin Invest; 1980 Jan; 65(1):103-8. PubMed ID: 6765955
[TBL] [Abstract][Full Text] [Related]
2. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.
Cohen A; Doyle D; Martin DW; Ammann AJ
N Engl J Med; 1976 Dec; 295(26):1449-54. PubMed ID: 825775
[TBL] [Abstract][Full Text] [Related]
3. Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions.
Rich KC; Majias E; Fox IH
N Engl J Med; 1980 Oct; 303(17):973-7. PubMed ID: 6774252
[No Abstract] [Full Text] [Related]
4. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
Edwards NL; Gelfand EW; Biggar D; Fox IH
J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
[No Abstract] [Full Text] [Related]
5. Immune cell function and recycling of purines.
Giblett ER
N Engl J Med; 1976 Dec; 295(24):1375-6. PubMed ID: 824556
[No Abstract] [Full Text] [Related]
6. Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.
Stoop JW; Zegers BJ; Hendrickx GF; van Heukelom LH; Staal GE; de Bree PK; Wadman SK; Ballieux RE
N Engl J Med; 1977 Mar; 296(12):651-5. PubMed ID: 402573
[TBL] [Abstract][Full Text] [Related]
7. Purine nucleoside phosphorylase deficiency. Evidence for molecular heterogeneity in two families with enzyme-deficient members.
Osborne WR; Chen SH; Giblett ER; Biggar WD; Ammann AA; Scott CR
J Clin Invest; 1977 Sep; 60(3):741-6. PubMed ID: 408378
[TBL] [Abstract][Full Text] [Related]
8. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
[TBL] [Abstract][Full Text] [Related]
9. Urinary purines in a patient with a severely defective T cell immunity and a purine nucleoside phosphorylase deficiency.
Wadman SK; de Bree PK; van Gennip AH; Stoop JW; Zegers BJ; Staal GE; Siegenbeek LH
Adv Exp Med Biol; 1977; 76A():471-6. PubMed ID: 404853
[No Abstract] [Full Text] [Related]
10. [Immune insufficiency in enzyme defects of purine metabolism].
Müller G
Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
[TBL] [Abstract][Full Text] [Related]
11. Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.
Fox IH; Kaminska J; Edwards NL; Gelfand E; Rich KC; Arnold WN
Biochem Genet; 1980 Apr; 18(3-4):221-34. PubMed ID: 6160848
[TBL] [Abstract][Full Text] [Related]
12. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
Hirschhorn R
Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
[No Abstract] [Full Text] [Related]
13. A new case of purine nucleoside phosphorylase deficiency: enzymologic, clinical, and immunologic characteristics.
Rijksen G; Kuis W; Wadman SK; Spaapen LJ; Duran M; Voorbrood BS; Staal GE; Stoop JW; Zegers BJ
Pediatr Res; 1987 Feb; 21(2):137-41. PubMed ID: 3103087
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of purine nucleosides in cultured fibroblasts from a patient with purine nucleoside phosphorylase deficiency and associated T-cell immunodeficiency.
Burke WG; Chen SH; Scott CR; Ammann AJ
J Cell Physiol; 1977 Jul; 92(1):109-13. PubMed ID: 408357
[TBL] [Abstract][Full Text] [Related]
15. An approach to the restoration of T cell function in a purine nucleoside phosphorylase deficient patient.
Zegers BJ; Stoop JW; Staal GE; Wadman SK
Ciba Found Symp; 1978; (68):231-53. PubMed ID: 115663
[TBL] [Abstract][Full Text] [Related]
16. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
Zegers BJ; Stoop JW
Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
[TBL] [Abstract][Full Text] [Related]
17. Inosine formation from hypoxanthine by intact erythrocytes and fibroblasts of an immunodeficient child with purine nucleoside phosphorylase deficiency.
Fairbanks LD; Webster DR; Simmonds HA; Potter CF; Watson AR
Adv Exp Med Biol; 1984; 165 Pt B():167-70. PubMed ID: 6426263
[No Abstract] [Full Text] [Related]
18. A patient with purine nucleoside phosphorylase deficiency: enzymological and metabolic aspects.
Siegenbeek Van Heukelom LH; Akkerman JW; Staal GE; De Bruyn CH; Stoop JW; Zegers BJ; De Bree PK; Wadman SK
Clin Chim Acta; 1977 Feb; 74(3):271-9. PubMed ID: 401697
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunodeficiency associated with nucleoside phosphorylase deficiency. Immunologic and biochemical studies.
Sandman R; Ammann AJ; Grose C; Wara DW
Clin Immunol Immunopathol; 1977 Sep; 8(2):247-53. PubMed ID: 198175
[No Abstract] [Full Text] [Related]
20. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
Hirschhorn R; Ratech H
Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
